The Novel Coronavirus COVID-19 Outbreak: Global Implications for Antimicrobial Resistance

Affiliations

¹ European Centre for Environment and Human Health, University of Exeter Medical School, Environment & Sustainability Institute, Penryn, Cornwall, United Kingdom.

Aimee K Murray. Front Microbiol. 2020.

. 2020 May 13:11:1020.

doi: 10.3389/fmicb.2020.01020. eCollection 2020.

¹ European Centre for Environment and Human Health, University of Exeter Medical School, Environment & Sustainability Institute, Penryn, Cornwall, United Kingdom.

No abstract available

Keywords: COVID-19; antibiotic resistance; antibiotics; antimicrobial resistance; coronavirus.

References

1. Baron S. A., Devaux C., Colson P., Raoult D., Rolain J. M. (2020). Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? Int. J. Antimicrob. Agents. 55:105944. 10.1016/j.ijantimicag.2020.105944 - DOI - PMC - PubMed
1. Buffet-Bataillon S., Tattevin P., Bonnaure-Mallet M., Jolivet-Gougeon A. (2012). Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds–a critical review. Int. J. Antimicrob. Agents. 39, 381–389. 10.1016/j.ijantimicag.2012.01.011 - DOI - PubMed
1. Canton R., Coque T. M. (2006). The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466–475. 10.1016/j.mib.2006.08.011 - DOI - PubMed
1. Cantón R., González-Alba J. M., Galán J. C. (2012). CTX-M enzymes: origin and diffusion. Front. Microbiol. 3:110. 10.3389/fmicb.2012.00110 - DOI - PMC - PubMed
1. Cascella M., Rajnik M., Cuomo A., Dulebohn S. C., Di Napoli R. (2020). Features, Evaluation and Treatment Coronavirus (COVID-19). (Treasure Island, FL: StatPearls Publishing; ). - PubMed